GB1185947A - Improvements in or relating to Cardioactive Compositions - Google Patents

Improvements in or relating to Cardioactive Compositions

Info

Publication number
GB1185947A
GB1185947A GB33695/68A GB3369568A GB1185947A GB 1185947 A GB1185947 A GB 1185947A GB 33695/68 A GB33695/68 A GB 33695/68A GB 3369568 A GB3369568 A GB 3369568A GB 1185947 A GB1185947 A GB 1185947A
Authority
GB
United Kingdom
Prior art keywords
compositions
july
cardioactive
relating
forms
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
GB33695/68A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Warner Lambert Co LLC
Original Assignee
Warner Lambert Pharmaceutical Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Warner Lambert Pharmaceutical Co filed Critical Warner Lambert Pharmaceutical Co
Publication of GB1185947A publication Critical patent/GB1185947A/en
Expired legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates

Abstract

1,185,947. Cardioactive compositions. WARNER-LAMBERT PHARMACEUTICAL CO. 15 July, 1968 [19 July, 1967; 27 July, 1967 (3)], No. 33695/68. Heading A5B. Compositions for treating angina pectoris comprise o-(3-isopropylamino-2-hydroxy propoxyl)-allyl benzene or a salt thereof and a compound selected from pentaerythritol tetranitrate, pentaerythritol trinitrate, erythritol tetranitrate and isosorbide. They may be in conventional forms for oral and parenteral administration including layered tablets with rapid and delayed release layers, such forms comprising conventional diluents and excipients.
GB33695/68A 1967-07-19 1968-07-15 Improvements in or relating to Cardioactive Compositions Expired GB1185947A (en)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US65435567A 1967-07-19 1967-07-19
US65633167A 1967-07-27 1967-07-27
US65633067A 1967-07-27 1967-07-27
US65632967A 1967-07-27 1967-07-27

Publications (1)

Publication Number Publication Date
GB1185947A true GB1185947A (en) 1970-03-25

Family

ID=27505283

Family Applications (1)

Application Number Title Priority Date Filing Date
GB33695/68A Expired GB1185947A (en) 1967-07-19 1968-07-15 Improvements in or relating to Cardioactive Compositions

Country Status (2)

Country Link
FR (1) FR7703M (en)
GB (1) GB1185947A (en)

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2822378A1 (en) * 2001-03-23 2002-09-27 Igen Ipsor Generiques New preparation method of two layer tablets comprises separate compression of two powders, one giving instant liberation and the other giving prolonged liberation of active material, e.g. nicardipine for the treatment of hypertension
WO2007044910A1 (en) * 2005-10-13 2007-04-19 Duke University Compositions for the treatment and prevention of heart disease and methods of using same

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2822378A1 (en) * 2001-03-23 2002-09-27 Igen Ipsor Generiques New preparation method of two layer tablets comprises separate compression of two powders, one giving instant liberation and the other giving prolonged liberation of active material, e.g. nicardipine for the treatment of hypertension
WO2007044910A1 (en) * 2005-10-13 2007-04-19 Duke University Compositions for the treatment and prevention of heart disease and methods of using same

Also Published As

Publication number Publication date
FR7703M (en) 1970-02-23

Similar Documents

Publication Publication Date Title
IL50836A (en) Dihydrocyclosphorin c,a process for the preparation thereoof and pharmaceutical compositions containing this compound
AU463074B2 (en) Orally effective analgetic composition
FI931031A (en) MOMETASONFUROATMONOHYDRAT, FOERFARANDE FOER DESS FRAMSTAELLNING OCH PHARMACEUTISKA SAMMANSAETTNINGAR
GB1310594A (en) Antidepressant compositions and dosage units
GB1185947A (en) Improvements in or relating to Cardioactive Compositions
IT7823561A0 (en) METHYLMETHIONINE-SULPHONIUM COMPOUNDS, PROCEDURE FOR THEIR PREPARATION, PHARMACEUTICAL COMPOSITIONS THAT CONTAIN THEM.
IT7927243A0 (en) FOR THEIR PREPARATION AND TRIAZINONE COMPOUNDS, PROCEDURES AND PHARMACEUTICAL COMPOSITIONS THAT CONTAIN THEM.
ES362231A1 (en) Dimethylbiguanide Derivative
GB1126153A (en) Novel polygalacturonic acid derivative
IE35507B1 (en) Anti-inflammatory preparations containing tetrahydrocarbazole derivatives
JPS5247506A (en) Nitrogen-containing powder-sintered high speed steel
JPS522485A (en) Radiation beam visible light converter
NZ182263A (en) 2-carboxyalkyl-4,4-dimethyl-1-hydroxy-alkyl-pyrrolidin-3,5-dione derivativesand pharmaceutical compositions
AU498557B2 (en) D-homosteroids & pharmaceutical compositions
JPS521687A (en) Cutter
GB1361779A (en) Vincamine salt and its use as a pharmaceutical composition
CA953715A (en) N(6)-(2,5-dimethylbenzyl)-2-chloroadenosine derivatives, process for their preparation and pharmaceutical compositions containing the same
JPS5247846A (en) Polyolefin compositions
JPS51119575A (en) Cutting ring
JPS5235642A (en) Organic photo-electroconductive material
JPS5242092A (en) Segment type display
JPS51131695A (en) Bill discriminator
GB1378296A (en) Pharmaceutical composition
JPS5225244A (en) Distributing panel
JPS5233948A (en) Polyurethane compositions having mproved whiteness retention

Legal Events

Date Code Title Description
PS Patent sealed
PLNP Patent lapsed through nonpayment of renewal fees